e-learning
resources
Vienna 2003
Sunday 28.09.2003
Clinical features in tuberculosis - II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC)
F. Bacakoglu, O. Kacmaz Basoglu, H. Toz, A. Atasever, S. Duman, K. Basak, A. Sayiner, A. Guzelant (Izmir, Turkey)
Source:
Annual Congress 2003 - Clinical features in tuberculosis - II
Session:
Clinical features in tuberculosis - II
Session type:
Thematic Poster Session
Number:
1020
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Bacakoglu, O. Kacmaz Basoglu, H. Toz, A. Atasever, S. Duman, K. Basak, A. Sayiner, A. Guzelant (Izmir, Turkey). Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC). Eur Respir J 2003; 22: Suppl. 45, 1020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Mycophenolate mofetil (MMF) rescue therapy in lung transplantation: results and pharmacokinetics
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002
Results of switch from mycophenolate mofetil to azathioprin after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004
Tacrolimus versus cyclosporine for lung transplant recipients in Portugal
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020
Use of mycophenolate mofetil for the treatment of hypersensitivity pneumonitis>
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Can mycophenolate mofetil 15 mg/kg/day attenuate experimental pulmonary fibrosis in rats?
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001
Safety and effectiveness of mycophenolate mofetil in interstitial lung diseases
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression?
Source: Eur Respir J, 57 (6) 2004354; 10.1183/13993003.04354-2020
Year: 2021
Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis. A retrospective study
Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2011
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004
Curcumin in combination with low-dose cyclosporine a in experimental airway transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 518s
Year: 2007
Mycophenolate mofetil: an effective corticosteroid-sparing drug in steroid-dependent asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 49s
Year: 2005
Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Mycophenolate mofetil and azathioprine in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Pneumocystis jiroveci Pneumonia prophylaxis in patients treated with mycophenolate mofetil for interstitial lung disease
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021
Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Methotrexate vs azathioprine in chronic sarcoidosis
Source: Annual Congress 2012 - Sarcoidosis
Year: 2012
Combined cytotoxic treatment (methotrexate and cyclophosphamide) in association with prednisone in sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 713s
Year: 2004
Case series reporting the effectiveness of mycophenolate mofetil in treatment-resistant asthma
Source: Eur Respir J 2013; 42: 1134-1137
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept